Psych CASC / OSCE · General adult psychiatry — psychosis
Explain treatment-resistant schizophrenia and clozapine — CASC communication station
MRCPsych/FRANZCP-style communication station: explain TRS without stigma, outline clozapine benefits and monitoring, address fears, safety-net risk, and check understanding.
On this page & tools
Target exams
Station brief
Format. Communication station, approximately 7–10 minutes active time after reading. You are the psychiatry registrar in the community psychosis clinic. [4]
Candidate instructions. Explain what treatment-resistant schizophrenia means in plain language, why his previous trials count as adequate failures, why clozapine is being recommended, what blood tests and side-effects to expect (including constipation and early fever/chest pain warnings), and how you will monitor safety and symptoms. Check understanding and invite questions. The examiner plays the patient. [4]
Candidate scenario
He completed risperidone 6 mg for 8 weeks and olanzapine 20 mg for 8 weeks with good adherence; voices and paranoia remain. He fears clozapine "destroys the bone marrow" and that weekly blood tests mean he is "too sick to work". He asks about "just using a monthly injection instead" and about "shock treatment he saw online." [1][2][4]
Marking domains
- Empathy, structure, agenda-setting
- Accurate non-stigmatising explanation of TRS (failed adequate trials, not personal failure)
- Clear clozapine plan: purpose, blood monitoring, myocarditis and constipation red flags
- Corrects "LAI fixes true TRS" misconception without dismissing LAIs for adherence
- Balanced ECT explanation as later option if needed, not punishment
- Safety-netting for suicidal thoughts and physical red flags
- Checks understanding / teach-back [4]
Reveal assessor key
Open and agenda-set. Name time; ask his main worries first (bone marrow fear, work, monthly injection, ECT). [4]
Explain TRS. "Treatment-resistant schizophrenia means the illness has not got enough better after two proper full-dose medicine trials done for long enough with good adherence. It is a medical description of how treatment has gone so far — not a judgement that you are weak or 'beyond help'. Many people still improve with the next step." [1][4]
Explain clozapine. Clozapine is the medicine with the strongest evidence when two proper antipsychotic trials have failed. We use regular blood tests because a drop in infection-fighting white cells is rare but serious — the monitoring system exists so we catch problems early. Early on we also watch for fever, fast heart rate or chest pain (heart inflammation risk) and we prevent constipation aggressively because bowel slowing can become dangerous. We start low and go slow. Smoking can change levels — tell us if you cut down or quit.[2][4]
LAI. A monthly injection is excellent when tablets are hard to take regularly. In your case the previous tablets were taken properly and still were not enough, so an injection of a similar medicine is unlikely to solve true treatment resistance by itself. Clozapine is still the right specialist step. [1][4]
ECT. If symptoms remain severe after a proper clozapine trial, ECT can sometimes be added in hospital under anaesthetic. It is not a punishment and not first-line before clozapine in your situation. We would discuss risks and benefits carefully if we ever get there.[4]
Safety and work. Blood tests are scheduled and many people continue work with planning. If passive thoughts become plans or intent, contact crisis services/emergency the same day. Fever, chest pain, severe constipation, or vomiting need urgent same-day care. Teach-back close. [3][4]
References
- [1]Howes OD, McCutcheon R, Agid O, et al. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology Am J Psychiatry, 2017.PMID 27919182
- [2]Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine Arch Gen Psychiatry, 1988.PMID 3046553
- [3]Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) Arch Gen Psychiatry, 2003.PMID 12511175
- [4]Galletly C, Castle D, Dark F, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders Aust N Z J Psychiatry, 2016.PMID 27106681